A Z Badros
Overview
Explore the profile of A Z Badros including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar S, Dimopoulos M, Kastritis E, Terpos E, Nahi H, Goldschmidt H, et al.
Leukemia
. 2017 Jun;
31(11):2443-2448.
PMID: 28620163
Introduction of new myeloma therapies offers new options for patients refractory to immunomodulatory drugs (IMiDs) and proteasome inhibitors (PIs). In this multicenter study, patients with relapsed multiple myeloma, who have...
2.
Yared J, Hardy N, Singh Z, Hajj S, Badros A, Kocoglu M, et al.
Bone Marrow Transplant
. 2016 Feb;
51(6):850-2.
PMID: 26828905
No abstract available.
3.
Badros A, Vij R, Martin T, Zonder J, Kunkel L, Wang Z, et al.
Leukemia
. 2013 Feb;
27(8):1707-14.
PMID: 23364621
This phase 2 study assessed the safety, pharmacokinetics, pharmacodynamics and efficacy of carfilzomib, a selective proteasome inhibitor, in patients with multiple myeloma and varying degrees of renal impairment, including patients...
4.
Fernandez de Larrea C, Kyle R, Durie B, Ludwig H, Usmani S, Vesole D, et al.
Leukemia
. 2013 Jan;
27(4):780-91.
PMID: 23288300
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells. It is classified as either primary PCL occurring at diagnosis...
5.
Phillips G, Meisenberg B, Reece D, Adams V, Badros A, Brunner J, et al.
Bone Marrow Transplant
. 2004 Feb;
33(8):781-7.
PMID: 14767498
High-dose chemotherapy using melphalan (HDMEL) is an important component of many conditioning regimens that are given before autologous hematopoietic stem cell transplantation (AHSCT). In contrast to the situation in myeloma,...